NO20044169L - Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme - Google Patents

Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme

Info

Publication number
NO20044169L
NO20044169L NO20044169A NO20044169A NO20044169L NO 20044169 L NO20044169 L NO 20044169L NO 20044169 A NO20044169 A NO 20044169A NO 20044169 A NO20044169 A NO 20044169A NO 20044169 L NO20044169 L NO 20044169L
Authority
NO
Norway
Prior art keywords
producing
methods
same
sex hormones
proteins capable
Prior art date
Application number
NO20044169A
Other languages
English (en)
Norwegian (no)
Inventor
Shigeru Fujimoto
Yasuhiro Goda
Masanao Katagiri
Original Assignee
Japan Enviro Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Enviro Chemicals Ltd filed Critical Japan Enviro Chemicals Ltd
Publication of NO20044169L publication Critical patent/NO20044169L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20044169A 2002-03-01 2004-09-30 Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme NO20044169L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002055669 2002-03-01
PCT/JP2003/002311 WO2003074704A1 (fr) 2002-03-01 2003-02-28 Proteines capables de se lier aux hormones sexuelles feminines et procede de preparation

Publications (1)

Publication Number Publication Date
NO20044169L true NO20044169L (no) 2004-11-16

Family

ID=27784617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044169A NO20044169L (no) 2002-03-01 2004-09-30 Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme

Country Status (5)

Country Link
US (1) US20060110771A1 (de)
EP (1) EP1486566A4 (de)
AU (1) AU2003211337A1 (de)
NO (1) NO20044169L (de)
WO (1) WO2003074704A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI622402B (zh) 2010-02-24 2018-05-01 免疫遺傳股份有限公司 葉酸受體１抗體類和免疫共軛物類及彼等之用途
BR112013025415B1 (pt) 2011-04-01 2021-03-16 Immunogen, Inc uso de um imunoconjugado antirreceptor de folato 1 (folr1)
US9200073B2 (en) 2012-08-31 2015-12-01 Immunogen, Inc. Diagnostic assays and kits for detection of folate receptor 1
CN113150145B (zh) 2013-08-30 2025-02-14 伊缪诺金公司 用于检测叶酸受体1的抗体和测定
CN116440279B (zh) 2015-09-17 2026-02-24 伊缪诺金公司 包含抗folr1免疫缀合物的治疗组合

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI913434A7 (fi) * 1990-07-16 1992-01-17 Technical Research Centre F Finland Rekombinanta fusionsproteiner vilka utsoendras.
US5342760A (en) * 1992-06-10 1994-08-30 Abbott Laboratories Determination of estradiol by competitive immunoassay
JP3525221B2 (ja) * 1993-02-17 2004-05-10 味の素株式会社 免疫抑制剤
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
IL111748A0 (en) * 1993-12-03 1995-01-24 Zeneca Ltd Proteins
AU5752696A (en) * 1995-05-18 1996-11-29 Regents Of The University Of Michigan, The Dna binding antibodies
US5977319A (en) * 1996-10-21 1999-11-02 Cambridge Antibody Technology Limited Specific binding members for estradiol; materials and methods
JPH10309198A (ja) * 1997-05-12 1998-11-24 Tosoh Corp 抗体、遺伝子及びキメラ抗体の製法
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
EP1258729A3 (de) * 2001-05-18 2004-01-02 Takeda Chemical Industries, Ltd. Verfahren zur Auswahl eines Antikörpers, einer Hybridomzelle, eines monoklonalen Antikörpers und seine Verwendung
JPWO2003101611A1 (ja) * 2002-05-31 2005-09-29 日本エンバイロケミカルズ株式会社 環境ホルモン類の分離材、濃縮方法およびクリーンアップ方法

Also Published As

Publication number Publication date
WO2003074704A1 (fr) 2003-09-12
US20060110771A1 (en) 2006-05-25
AU2003211337A1 (en) 2003-09-16
EP1486566A4 (de) 2005-10-12
EP1486566A1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
NO20031776D0 (no) Null-boringskomplettering og produksjonssystem
IS7369A (is) Aðferð og tæki til örflögunýmyndunar
DK1628749T3 (da) Anordninger og fremgangsmåder til biomateriel produktion
NO20051397D0 (no) Enkeltfase samlingsapparat og fremgangsmate
NO20052014D0 (no) Prosess og system for behandling av bronner
DK1620551T3 (da) Phospholipase og fremgangsmåde til fremstilling deraf
DK2336147T3 (da) Beta-immunogen-peptid-bærerkonjugater og fremgangsmåder til fremstilling deraf
AU2003236303A1 (en) Organ connecting device and method for using the device
DK1271537T3 (da) Fremgangsmåde og indretning til simplificering af adgangen til metadata
AU2003237884A1 (en) Method and device for anastomoses
IS7645A (is) Stillar glúkósteraviðtaka og aðferð
DK1551332T3 (da) Fladstrikket stent og fremgangsmåde til fremstilling deraf
EP1492049A4 (de) Erzeugung von gesichts-metadaten
NO20043839L (no) Havbunnsbasert intervensjonssystem, fremgangsmate for og komponeter i dette
AU2003301760A8 (en) Stent compression method
IS7726A (is) Pyrazólólpyridín og aðferðir til þess að búa þau til og nota
ATE496940T1 (de) Ghrelin-analoga
NO20055778D0 (no) Folgesystem og assosiert fremgangsmate
NO20051875D0 (no) Kjoleror og fremgangsmate for bruk av dette
GB2431061B (en) Synchronous follow-up apparatus and synchronous follow-up method
BR0215897B1 (pt) prepreg e método para sua produção
NO20044169L (no) Proteiner i stand til a binde kvinnelige kjonnshormoner og fremgangsmate for a produsere de samme
AU2003226899A8 (en) Human diabetes-mediating proteins
NO20044178L (no) Proteiner i stand til a binde miljohormoner og fremgangsmate for a produsere de samme
GB0229535D0 (en) Metadata provision system and method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application